AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]
GSK announced that the European Commission has approved Exdensur (depemokimab) [...]
AstraZeneca and Amgen’s Tezspire has met both co-primary and key [...]
GSK announced that the European Commission has approved Exdensur (depemokimab) [...]